CORD-19:c654596857bce9cdd64ffc51842048643107348c / 43169-43465 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T361","span":{"begin":158,"end":296},"obj":"Sentence"},{"id":"T42457","span":{"begin":158,"end":296},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"a CEA, DRM, Fontenay-aux-Roses, France , b INRA, Physiologie Animale, Jouy-en-Josas, France , c CEA, CRSSA, EPHE, DRM, Fontenay-aux-Roses, France Background: Type I interferons (IFN) exhibit efficient antiviral activities notably against HIV, but severe side effects restrict their clinical uses."}

    Epistemic_Statements

    {"project":"Epistemic_Statements","denotations":[{"id":"T64","span":{"begin":0,"end":296},"obj":"Epistemic_statement"}],"text":"a CEA, DRM, Fontenay-aux-Roses, France , b INRA, Physiologie Animale, Jouy-en-Josas, France , c CEA, CRSSA, EPHE, DRM, Fontenay-aux-Roses, France Background: Type I interferons (IFN) exhibit efficient antiviral activities notably against HIV, but severe side effects restrict their clinical uses."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T361","span":{"begin":158,"end":296},"obj":"Sentence"}],"text":"a CEA, DRM, Fontenay-aux-Roses, France , b INRA, Physiologie Animale, Jouy-en-Josas, France , c CEA, CRSSA, EPHE, DRM, Fontenay-aux-Roses, France Background: Type I interferons (IFN) exhibit efficient antiviral activities notably against HIV, but severe side effects restrict their clinical uses."}